Pfizer excels on divided US | Financial


Pfizer may be requesting accelerated approval of its potential vaccine against Covid-19 from the US drug watchdog in late November. This step depends on the results of a large-scale study into the effectiveness and safety of the drug, CEO Albert Bourla writes in an open letter. The US regulator FDA can give the green light to the use of medicines in an emergency before they have gone through an official and lengthy approval process.

Also Boeing (+ 1.9%) knew the attention was focused on themselves. According to the European aviation regulator EASA, the Boeing 737 MAX is safe and will probably be able to fly again before the end of the year.

Investors also reacted to the disappointing quarterly figures of Schlumberger (-9%), where again a loss and a considerably lower turnover went into the books. The oil services provider expects it to take another year before the company makes as much profit again as before the corona crisis.

Truck builder Navistar posted a 22.9% share price explosion after reaching an agreement with Volkswagen subsidiary Traton on an acquisition. Traton will pay approximately $ 3.7 billion for Navistar, in which it already had an interest of just under 17%.

Uber (-1.6%) would look at alternatives to Uber Elevate, the company’s service that wants to offer taxi rides in small vertical take-off and landing planes. The company behind taxi service Uber and food delivery company Uber Eats is considering collaborations or a partial sale, the American medium Axios reports.

Furthermore Twitter (-0.5%) have relaxed policies about blocking potentially hacked information, following a storm of criticism over alleged bias in the run-up to the US election. Twitter recently blocked a message damaging to presidential candidate Joe Biden about his son’s affairs in Ukraine, in which Biden was allegedly involved as vice president at the time. The company now wants to be more careful with such blockages based on suspicions of hacked information.

Before trading on Wall Street got underway this afternoon, investors were presented with better-than-expected US retail sales figures. However, industrial production fell.

DFT Daily

The most important financial news every morning.

Invalid email address. Please fill in again.

Read our privacy policy here.


Source link by https://www.telegraaf.nl/financieel/1930214101/pfizer-blinkt-uit-op-verdeelde-beurzen-vs

*The article has been translated based on the content of Source link by https://www.telegraaf.nl/financieel/1930214101/pfizer-blinkt-uit-op-verdeelde-beurzen-vs
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!

These were the details of the news Pfizer excels on divided US | Financial for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Toyota to build $1.29bn battery plant for hybrids, EVs in US
NEXT Leaks reveal the specifications of the new “MacBook Pro” from Apple